Sabroe R A, Archer C B, Harlow D, Bradfield J W, Peachey R D
Department of Dermatology, Bristol Royal Infirmary, U.K.
Br J Dermatol. 1996 Aug;135(2):314-6.
We report two patients with minocycline-induced pigmentation of the sclerae. Cutaneous pigmentation is a well-recognized complication of minocycline therapy, but only five cases of pigmentation of the sclerae have been described previously. These five patients have a number of features in common with the two reported here. We propose that these patients represent the most severe end of the spectrum of minocycline-induced cutaneous changes. Patients should be warned about the possibility of the occurrence of pigmentary changes before starting therapy.
我们报告了两例米诺环素诱发巩膜色素沉着的患者。皮肤色素沉着是米诺环素治疗一种公认的并发症,但此前仅描述过5例巩膜色素沉着病例。这5例患者与本文报告的2例有许多共同特征。我们认为这些患者代表了米诺环素诱发皮肤改变谱的最严重一端。在开始治疗前,应告知患者色素改变发生的可能性。